Drug Enforcement Administration February 2022 – Federal Register Recent Federal Regulation Documents

Bulk Manufacturer of Controlled Substances Application: Cedarburg Pharmaceuticals
Document Number: 2022-04064
Type: Notice
Date: 2022-02-25
Agency: Drug Enforcement Administration, Department of Justice
Cedarburg Pharmaceuticals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: S&B Pharma LLC
Document Number: 2022-04062
Type: Notice
Date: 2022-02-25
Agency: Drug Enforcement Administration, Department of Justice
S&B Pharma LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Importer of Controlled Substances Application: Lyndra Therapeutics
Document Number: 2022-04061
Type: Notice
Date: 2022-02-25
Agency: Drug Enforcement Administration, Department of Justice
Lyndra Therapeutics has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Synthcon LLC
Document Number: 2022-04057
Type: Notice
Date: 2022-02-25
Agency: Drug Enforcement Administration, Department of Justice
Synthcon LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Importer of Controlled Substances Application: Mylan Inc.
Document Number: 2022-03907
Type: Notice
Date: 2022-02-24
Agency: Drug Enforcement Administration, Department of Justice
Mylan Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Importer of Controlled Substances Application: Scottsdale Research Institute
Document Number: 2022-03904
Type: Notice
Date: 2022-02-24
Agency: Drug Enforcement Administration, Department of Justice
Scottsdale Research Institute has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Importer of Controlled Substances Application: Myonex Inc.
Document Number: 2022-03903
Type: Notice
Date: 2022-02-24
Agency: Drug Enforcement Administration, Department of Justice
Myonex Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Importer of Controlled Substances Application: Noramco Coventry LLC
Document Number: 2022-03902
Type: Notice
Date: 2022-02-24
Agency: Drug Enforcement Administration, Department of Justice
Noramco Coventry LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Johnson Matthey Pharmaceutical Materials Inc.
Document Number: 2022-03901
Type: Notice
Date: 2022-02-24
Agency: Drug Enforcement Administration, Department of Justice
Johnson Matthey Pharmaceutical Materials Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute
Document Number: 2022-03900
Type: Notice
Date: 2022-02-24
Agency: Drug Enforcement Administration, Department of Justice
Scottsdale Research Institute, has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Benuvia Therapeutics Inc.
Document Number: 2022-03897
Type: Notice
Date: 2022-02-24
Agency: Drug Enforcement Administration, Department of Justice
Benuvia Therapeutics Inc., has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
John X. Qian, M.D.; Decision and Order
Document Number: 2022-02973
Type: Notice
Date: 2022-02-11
Agency: Drug Enforcement Administration, Department of Justice
Exempt Chemical Preparations Under the Controlled Substances Act
Document Number: C1-2022-01112
Type: Notice
Date: 2022-02-03
Agency: Drug Enforcement Administration, Department of Justice
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.